{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:37:29Z","timestamp":1770892649243,"version":"3.50.1"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.yebeh.2016.11.008","type":"journal-article","created":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T02:01:01Z","timestamp":1486519261000},"page":"153-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Treatment issues for children with epilepsy transitioning to adult care"],"prefix":"10.1016","volume":"69","author":[{"given":"Rima","family":"Nabbout","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol S","family":"Camfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle M","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Arzimanoglou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce A","family":"Cramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline A","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Kossoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Mula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R","family":"Camfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2016.11.008_bb0005","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.yebeh.2016.11.009","article-title":"The transition from pediatric to adult care for youth with epilepsy: basic biological, sociological, and psychological issues","volume":"69","author":"Camfield","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yebeh.2016.11.010","article-title":"Outcome of childhood onset epilepsy from adolescence to young adulthood","volume":"69","author":"Nabbout","year":"2017","journal-title":"Epilepsy Behav"},{"issue":"9242","key":"10.1016\/j.yebeh.2016.11.008_bb0015","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(00)03157-3","article-title":"Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group","volume":"356","author":"Chiron","year":"2000","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.yebeh.2016.11.008_bb0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/epi.12708","article-title":"Pharmacology aspects during transition and at transfer in patients with epilepsy","volume":"55","author":"Chiron","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0025","article-title":"Audit of use of stiripentol in adults with Dravet syndrome","author":"Balestrini","year":"2016","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0030","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/brain\/awr129","article-title":"Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology","volume":"134","author":"Catarino","year":"2011","journal-title":"Brain"},{"issue":"8685","key":"10.1016\/j.yebeh.2016.11.008_bb0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0140-6736(90)90660-W","article-title":"Vigabatrin in infantile spasms","volume":"335","author":"Chiron","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0920-1211(96)01006-6","article-title":"Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis","volume":"26","author":"Chiron","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0045","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1111\/j.1528-1167.2010.02772.x","article-title":"Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review","volume":"51","author":"Maguire","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0050","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1212\/WNL.0000000000001069","article-title":"Vigabatrin retinal toxicity in children with infantile spasms: an observational cohort study","volume":"83","author":"Westall","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0065","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.clp.2009.08.001","article-title":"Neonatal seizures: an update on mechanisms and management","volume":"36","author":"Jensen","year":"2009","journal-title":"Clin Perinatol"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2016.11.008_bb0070","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.eplepsyres.2005.07.017","article-title":"Pharmacological and clinical aspects of antiepileptic drug use in the elderly","volume":"68","author":"Perucca","year":"2006","journal-title":"Epilepsy Res"},{"issue":"369(9566)","key":"10.1016\/j.yebeh.2016.11.008_bb0075","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"SANAD study group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"24","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0085","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1212\/WNL.0b013e31826d5ec0","article-title":"Efficacy of antiepileptic drugs in adults predicts efficacy in children: a systematic review","volume":"79","author":"Pellock","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0013-4694(97)00084-9","article-title":"Rett syndrome: characterization of seizures versus non-seizures","volume":"106","author":"Glaze","year":"1998","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/pcn.12245","article-title":"Paroxysmal non-epileptic events in infants and toddlers: a phenomenologic analysis","volume":"69","author":"Chen","year":"2015","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0100","doi-asserted-by":"crossref","DOI":"10.1053\/seiz.2000.0409","article-title":"An estimate of the prevalence of psychogenic non-epileptic seizures","volume":"9","author":"Benbadis","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0013-9580.2004.37803.x","article-title":"Seizure recurrence after planned discontinuation of antiepileptic drugs in seizure-free patients after epilepsy surgery: a review of current clinical experience","volume":"45","author":"Schmidt","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2003.10.004","article-title":"How effective is surgery to cure seizures in drug-resistant temporal lobe epilepsy?","volume":"56","author":"Schmidt","year":"2003","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/brain\/awl316","article-title":"Long-term outcomes in epilepsy surgery: antiepileptic drugs, mortality, cognitive and psychosocial aspects","volume":"130","author":"T\u00e9llez-Zenteno","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0120","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3171\/2015.4.JNS14438","article-title":"Hemispheric surgery for refractory epilepsy: a systematic review and meta-analysis with emphasis on seizure predictors and outcomes","volume":"124","author":"Hu","year":"2016","journal-title":"J Neurosurg"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.eplepsyres.2014.01.024","article-title":"Management of antiepileptic drugs following epilepsy surgery: a meta-analysis","volume":"108","author":"Ladino","year":"2014","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0130","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S1474-4422(11)70047-3","article-title":"The pharmacological treatment of epilepsy in adults","volume":"10","author":"Perucca","year":"2011","journal-title":"Lancet Neurol"},{"issue":"Suppl. 3","key":"10.1016\/j.yebeh.2016.11.008_bb0135","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1111\/j.1528-1157.1998.tb05118.x","article-title":"Antiepileptic drug-induced worsening of seizures in children","volume":"39","author":"Guerrini","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0140","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2165\/00003495-200666140-00004","article-title":"Combination therapy in epilepsy: when and what to use","volume":"66","author":"Kwan","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0145","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2147\/TCRM.S55930","article-title":"Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox-Gastaut syndrome","volume":"11","author":"Faulkner","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/j.1875-9114.2012.01028.x","article-title":"Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes","volume":"32","author":"Walzer","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0155","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0387-7604(12)80025-8","article-title":"Monitoring of concentrations of clobazam and norclobazam in serum and saliva of children with epilepsy","volume":"13","author":"Bardy","year":"1991","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0160","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1017\/S0012162206002143","article-title":"Long-term use of the ketogenic diet in the treatment of epilepsy","volume":"48","author":"Groesbeck","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0165","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1001\/jama.290.7.912","article-title":"Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children","volume":"290","author":"Kwiterovitch","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0170","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1528-1167.2009.02488.x","article-title":"Long-term outcomes of children treated with ketogenic diet in the past","volume":"51","author":"Patel","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clnu.2012.05.019","article-title":"Catch-up growth after long-term implementation and weaning from ketogenic diet in pediatric epileptic patients","volume":"32","author":"Kim","year":"2013","journal-title":"Clin Nutr"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0180","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3945\/ajcn.2008.26099","article-title":"Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet","volume":"88","author":"Bergqvist","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0185","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.nut.2014.01.005","article-title":"Long-term effects of a ketogenic diet on body composition and bone mineralization in GLUT-1 deficiency syndrome: a case series","volume":"30","author":"Bertoli","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0190","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.seizure.2013.12.002","article-title":"The impact of the ketogenic diet on arterial morphology and endothelial function in children and young adults with epilepsy: a case-control study","volume":"23","author":"Coppola","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ejpn.2014.03.006","article-title":"Effects of ketogenic diet on vascular function","volume":"18","author":"Kapetanakis","year":"2014","journal-title":"Eur J Pediatr Neurol"},{"issue":"9","key":"10.1016\/j.yebeh.2016.11.008_bb0200","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.braindev.2016.03.009","article-title":"Does ketogenic diet have any negative effect on cardiac systolic and diastolic functions in children with intractable epilepsy? One-year follow-up results","volume":"38","author":"Ozdemir","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.seizure.2013.03.005","article-title":"Transitioning pediatric patients receiving ketogenic diets for epilepsy into adulthood","volume":"22","author":"Kossoff","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0210","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199806253382602","article-title":"A comparison of rectal diazepam gel and placebo for acute repetitive seizures","volume":"338","author":"Dreifuss","year":"1998","journal-title":"N Engl J Med"},{"issue":"9153","key":"10.1016\/j.yebeh.2016.11.008_bb0215","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(98)06425-3","article-title":"Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial","volume":"353","author":"Scott","year":"1999","journal-title":"Lancet"},{"issue":"9481","key":"10.1016\/j.yebeh.2016.11.008_bb0220","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","article-title":"Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial","volume":"366","author":"McIntyre","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.yebeh.2016.11.008_bb0225","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp.47.3.235","article-title":"A clinical trial of single dose rectal and oral administration of diazepam for the prevention of serial seizures in adult epileptic patients","volume":"47","author":"Milligan","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl. 5","key":"10.1016\/j.yebeh.2016.11.008_bb0230","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1528-1157.1994.tb05978.x","article-title":"Clobazam in the treatment of epilepsy: a review of the literature","volume":"35","author":"Remy","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0235","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1755-5949.2010.00167.x","article-title":"Acute drug administration in epilepsy: a review","volume":"17","author":"Wolf","year":"2011","journal-title":"CNS Neurosci Ther"},{"issue":"9","key":"10.1016\/j.yebeh.2016.11.008_bb0240","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s40263-015-0271-x","article-title":"A common reference-based indirect comparison meta-analysis of buccal versus intranasal midazolam for early status epilepticus","volume":"29","author":"Brigo","year":"2015","journal-title":"CNS Drugs"},{"issue":"7","key":"10.1016\/j.yebeh.2016.11.008_bb0245","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"NETT investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0250","author":"NICE"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0255","first-page":"47","article-title":"Intermittent clobazam for catamenial epilepsy: tolerance avoided","author":"Feely","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0260","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"Medication compliance: the importance of the dosing regimen","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0265","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.1989.03420220087032","article-title":"How often is medication taken as prescribed? A novel assessment technique","volume":"261","author":"Cramer","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0270","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archinte.1990.00390190143023","article-title":"Compliance declines between clinic visits","volume":"150","author":"Cramer","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00005053-199901000-00009","article-title":"Enhancing medication compliance for people with serious mental illness","volume":"187","author":"Cramer","year":"1999","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"10.1016\/j.yebeh.2016.11.008_bb0280","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0285","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.seizure.2011.06.004","article-title":"Depression and anxiety in childhood epilepsy: a review","volume":"20","author":"Reilly","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1528-1157.1997.tb01102.x","article-title":"Patient-validated content of epilepsy-specific quality-of-life measurement","volume":"38","author":"Gillam","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0295","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1474-4422(07)70175-8","article-title":"Epilepsy and risk of suicide: a population-based case-control study","volume":"6","author":"Christensen","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0300","first-page":"1","article-title":"Depression in children and adolescents with epilepsy: a 15year research review of prevalence, and demographic and seizure related correlates","volume":"23","author":"Seyfhashemi","year":"2013","journal-title":"Iran J Pediatr"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0305","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/01.wnl.0000252813.86812.81","article-title":"Hippocampal 1H-MRSI correlates with severity of depression symptoms in temporal lobe epilepsy","volume":"68","author":"Gilliam","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0310","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.yebeh.2015.09.004","article-title":"Symptoms of anxiety and depression in school-aged children with active epilepsy: a population-based study","volume":"52","author":"Reilly","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0315","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.yebeh.2009.07.039","article-title":"Conversations between community-based neurologists and patients with epilepsy: results of an observational linguistic study","volume":"16","author":"Gillam","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0320","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1474-4422(06)70415-X","article-title":"Rapid detection of major depression in epilepsy: a multicentre study","volume":"5","author":"Gilliam","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0325","first-page":"26","article-title":"Managing depressive disorders in patients with epilepsy","volume":"4","author":"Trivedi","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0330","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1542\/peds.2009-2317","article-title":"Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts","volume":"125","author":"Schneeweiss","year":"2010","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.yebeh.2016.11.008_bb0335","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-3787","article-title":"Neurobehavioral comorbidities in children with active epilepsy: a population-based study","volume":"133","author":"Reilly","year":"2014","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.yebeh.2016.11.008_bb0340","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1469-8749.2008.03172.x","article-title":"Prevalence of psychopathology in childhood epilepsy: categorical and dimensional measures","volume":"51","author":"Dunn","year":"2009","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0345","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/epi.12897","article-title":"Attention-deficit\/hyperactivity disorder symptoms in adults with self-reported epilepsy: results from a national epidemiologic survey of epilepsy","volume":"56","author":"Ettinger","year":"2015","journal-title":"Epilepsia"},{"issue":"10024","key":"10.1016\/j.yebeh.2016.11.008_bb0350","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(15)00238-X","article-title":"Attention deficit hyperactivity disorder","volume":"387","author":"Thapar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0355","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.yebeh.2010.06.018","article-title":"Violence and postictal psychosis: a comparison of postictal psychosis, interictal psychosis, and postictal confusion","volume":"19","author":"Kanemoto","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0360","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJM198109173051231","article-title":"Special report. The nature of aggression during epileptic seizures","volume":"305","author":"Delgado-Escueta","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0365","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1006\/ebeh.2000.0061","article-title":"Aggression and violence in patients with epilepsy","volume":"1","author":"Marsh","year":"2000","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 2","key":"10.1016\/j.yebeh.2016.11.008_bb0370","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1111\/j.1528-1157.1986.tb05742.x","article-title":"Epilepsy and violence: medical and legal issues","volume":"27","author":"Treiman","year":"1986","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0375","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/pr.115.012021","article-title":"Epilepsy, antiepileptic drugs, and aggression: an evidence-based review","volume":"68","author":"Brodie","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0380","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.yebeh.2012.09.018","article-title":"Antiepileptic drug effects on mood and behavior: molecular targets","volume":"26","author":"Perucca","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2009.0238","article-title":"Antiepileptic drugs and psychopathology of epilepsy: an update","volume":"11","author":"Mula","year":"2009","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0390","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/YCO.0000000000000132","article-title":"An update on pharmacotherapy for autism spectrum disorder in children and adolescents","volume":"28","author":"Young","year":"2015","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0395","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2006.09.023","article-title":"Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports","volume":"62","author":"Alper","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0400","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1528-1157.1997.tb01241.x","article-title":"Social adjustment and competence 35years after onset of childhood epilepsy: a prospective controlled study","volume":"38","author":"Jalava","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0405","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1528-1167.2009.02505.x","article-title":"Long-term employment of adults with childhood-onset epilepsy: a prospective population-based study","volume":"51","author":"Sillanp\u00e4\u00e4","year":"2010","journal-title":"Epilepsia"},{"issue":"13","key":"10.1016\/j.yebeh.2016.11.008_bb0410","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1212\/WNL.0000000000000267","article-title":"Rolandic epilepsy has little effect on adult life 30years later: a population-based study","volume":"82","author":"Camfield","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0415","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3944","article-title":"Determinants of social outcomes in adults with childhood-onset epilepsy","author":"Berg","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0420","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1111\/j.1528-1167.2011.03170.x","article-title":"Outcomes of childhood epilepsy at age 33years: a population-based birth-cohort study","volume":"52","author":"Chin","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0425","first-page":"396","article-title":"Characteristics of medical-pediatric practice","volume":"84","author":"Fortuna","year":"2009","journal-title":"Acad Ed"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0430","volume":"7","author":"Jackson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0435","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.seizure.2016.04.004","article-title":"Long-term effects of a multidisciplinary transition intervention from paediatric to adult care in patients with epilepsy","volume":"38","author":"Geerlings","year":"2016","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.yebeh.2016.11.008_bb0440","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1046\/j.1528-1157.2002.23801.x","article-title":"The efficacy of an educational treatment program for patients with epilepsy (MOSES): results of a controlled, randomized study. Modular service package epilepsy","volume":"43","author":"May","year":"2002","journal-title":"Epilepsia"},{"issue":"315(18)","key":"10.1016\/j.yebeh.2016.11.008_bb0445","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.5453","article-title":"Treatment of attention deficit\\hyperactivity disorder in adolescents: a systematic review","volume":"10","author":"Chan","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0450","article-title":"Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18years","volume":"12","author":"Storeb\u00f8","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0455","first-page":"CD005041","article-title":"Cochrane database","volume":"9","author":"Epstein","year":"2014","journal-title":"Syst Rev"},{"issue":"5","key":"10.1016\/j.yebeh.2016.11.008_bb0460","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/pch\/21.5.247","article-title":"Imagine a mental health service that builds stronger families","volume":"21","author":"Lingley-Pottie","year":"2016","journal-title":"Paediatr Child Health"},{"key":"10.1016\/j.yebeh.2016.11.008_bb0465","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.acap.2014.03.008","article-title":"The transition readiness assessment questionnaire (TRAQ): its factor structure, reliability, and validity","volume":"14","author":"Wood","year":"2014","journal-title":"Acad Pediatr"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501630631X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501630631X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T22:13:38Z","timestamp":1601590418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501630631X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":91,"alternative-id":["S152550501630631X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.11.008","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment issues for children with epilepsy transitioning to adult care","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}